53 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
1 Jun 23
Oncorus Announces Workforce Reduction Plan
4:34pm
alternatives for restructuring and resolving its liabilities, including an orderly winddown.
About Oncorus
Oncorus is focused on driving innovation in RNA
8-K
EX-99.1
ONCR
Oncorus, Inc.
22 May 23
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
4:13pm
opportunities or additional financing activities.
About Oncorus
Oncorus is focused on driving innovation in RNA medicines by developing next-generation
8-K
EX-99.1
ONCR
Oncorus, Inc.
30 Nov 22
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
7:07am
of the call.
About Oncorus
At Oncorus, we are focused on driving innovation in RNA medicines by developing next-generation immunotherapies to stimulate
8-K
EX-99.1
zvo7fuu3nab2ik
2 Nov 22
Oncorus Reports Third Quarter 2022 Financial Results and Provides Business Updates
7:11am
8-K
EX-99.1
kv0n cq255fnvgi1
4 Aug 22
Oncorus Reports Second Quarter 2022 Financial Results and Provides Business Updates
9:04am
8-K
EX-99.1
b5jceipo558otbv079l
23 Jun 22
Oncorus Appoints Douglas Fambrough to Board of Directors
7:21am
8-K
EX-99.1
7e1kn2
4 May 22
Oncorus Reports First Quarter 2022 Financial Results and Provides Business Updates
7:15am
8-K
EX-99.1
jot6vmtcrgla
5 Apr 22
Entry into a Material Definitive Agreement
7:10am
8-K
EX-99.1
qaa51c55wt7 m5cg19d
9 Mar 22
Oncorus Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:46am
8-K
EX-99.1
pqjvis
12 Nov 21
Entry into a Material Definitive Agreement
7:45am
8-K
EX-99.1
rlwl56t1398rurc05y
9 Nov 21
Regulation FD Disclosure
8:10am
8-K
EX-99.1
ot6nqnsf
3 Nov 21
Oncorus Reports Third Quarter 2021 Financial Results and Provides Business Updates
7:18am
8-K
EX-99.1
727o21 x68kag102
4 Aug 21
Oncorus Reports Second Quarter 2021 Financial Results and Provides Business Highlights
7:09am